OXFEN C

Country: New Zealand

Language: English

Source: Ministry for Primary Industries

Active ingredient:

oxfendazole

Available from:

Boehringer Ingelheim Animal Health New Zealand Limited

INN (International Name):

oxfendazole

Composition:

oxfendazole 90.6 g/litre

Therapeutic area:

Endoparasiticide

Authorization status:

ACVM Registered

Authorization date:

1992-07-01

Summary of Product characteristics

Product : Oxfen C
Date: 15 July 2020
ACVM No.: A006575
Page
1
of
4
FRONT LABEL
WARNING
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
OXFEN C
LOW VOLUME OXFENDAZOLE DRENCH
FOR CATTLE AND DEER
For the control of roundworm, lungworm, and tapeworm in cattle and
deer, and type II
_Ostertagia_ in cattle.
Contains: 90.6 g/L oxfendazole
NET CONTENTS: 5 LITRES / 20 LITRES
Please read labels before use
Product : Oxfen C
Date: 15 July 2020
ACVM No.: A006575
Page
2
of
4
BACK LABEL
WARNING
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
OXFEN C
LOW VOLUME OXFENDAZOLE DRENCH FOR CATTLE AND DEER
CONTAINS:
90.6 g/L oxfendazole.
OXFEN C contains oxfendazole, a member of the benzimidazoles. It is
effective against
internal parasites sensitive to this family.
For the control of sensitive mature and immature _Haemonchus,
Ostertagia, _
_Trichostrongylus, Nematodirus, Cooperia, Strongyloides, Bunostomum, _
_Oesophagostomum, Chabertia, Trichuris, Dictyocaulus_ and _Moniezia_
in cattle and deer,
and type II _Ostertagia_ in cattle.
Resistance can develop to any anthelmintic. It is advisable that a
resistance test be
conducted regularly when using any parasite treatment. Ask your local
veterinary
practitioner or animal health adviser for recommended parasite
management practices
for your area to reduce development of resistance.
IT IS AN OFFENCE FOR USERS OF THIS PRODUCT TO CAUSE RESIDUES EXCEEDING
THE RELEVANT
MRL IN THE FOOD NOTICE: MAXIMUM RESIDUE LEVELS FOR AGRICULTURAL
COMPOUNDS.
WITHHOLDING PERIOD:
MEAT: Cattle and deer producing meat or offal for human consumption
must not be sold
for slaughter either during treatment or within 10 days of the last
treatment.
MILK: Milk intended for sale for human consumption must be discarded
during treatment
and for not less than 5 days following the last treatment.
BY LAW THE USER MUST TAKE DUE CARE, OBTAINING EXPERT ADVICE WHEN
NECESSARY, TO
AVOID UNNECESSARY PAIN AND DISTRESS WHEN USING THE PRODUCT OTHER THAN
AS
DIRECTED ON THE LABEL.
DIRECTIONS FOR USE:
SHAKE WELL BEFORE USE.